Novo Nordisk said on Thursday its experimental obesity drug CagriSema significantly reduced blood pressure in a late-stage ...

Novo Nordisk expects global sales to decline by low-single-digit percentage in 2026 after the drugmaker unveiled a deal on ...

U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...

U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...

Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

Novo Nordisk's experimental drug, CagriSema, shows promise beyond weight loss, potentially offering significant ...

Big Danish drugmaker Novo Nordisk (NYSE: NVO) reported its third-quarter results on Wednesday, Nov. 5. Although sales and ...

Danish company is battling with Pfizer for US biotech as they seek edge in growing market for weight-loss drugs ...

A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like ...

Novo Nordisk executive Gordon Findlay was standing behind Donald Trump at a press conference inside the White House when he ...

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs ...